Clinical trial
Phase I Study of Intrathecal Mafosfamide
NCT00001251 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001251 |
|---|---|
| Title | Phase I Study of Intrathecal Mafosfamide |
| Official title | Phase I Study of Intrathecal Mafosfamide |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Meningeal Neoplasm |
| Intervention type | Drug |
| Interventions | Mafosfamide |
| Enrollment | 65 |
| Start date | Nov 1, 1989 |
| Completion | Nov 1, 2003 |
| First posted | Nov 4, 1999 |
| Last update posted | Aug 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: